Clinical Value and Efficacy Index of Lymphadenectomy for Thoracic Escc

Completed

• Conditions: Esophageal Cancer

• Registration Number: NCT05604664
• Lead Sponsor: Yongtao Han

Brief Summary

The goal of this observational study is to to clarify the focus of lymph node dissection during esophagectomy.. The main question\[s\] it aims to answer is:

* provide a basis for accurate staging and the relationship between OS and lymph node dissection

Detailed Description

Not available

Study Timeline

• Study Start: 2022-05-01
• Primary Completion: 2022-10-01
• Study Completion: 2022-10-10
• Study First Submitted: 2022-10-29
• Status Verified: 2022-11
• Study First Submitted QC: 2022-11-02
• Study First Posted: 2022-11-03
• Last Update Submitted: 2022-11-03
• Last Update Posted: 2022-11-04

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1727

Inclusion Criteria

1. Pathologic findings proved ESCC (8th AJCC/UICC stage T1b-4aN0-3M0)
2. Underwent esophagecomy (two-field or three-field LN dissection)
3. The primary tumor was thoracic ESCC

Exclusion Criteria

1. Located outside the thoracic
2. Patients underwent salvage or R1/R2 esophagecomy
3. The number of resected lymph nodes (RLNs) less than 15
4. With neoadjuvant therapy(NT) or salvage chemoradiotherapy(SCRT)

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
5-year survival rate of lymph nodes metastases (%) in patients	2010.1.1-2017.12.30	Surgical data were retrospectively collected

Trial Locations

Locations (1)

Sichuan Cancer Hospital and Research Institute; 🇨🇳 Chengdu, Sichuan, China